Tilray, Inc. (TLRY) financial statements (2021 and earlier)

Company profile

Business Address 1100 MAUGHAN ROAD
NANAIMO, BC V9X 1J2
State of Incorp. DE
Fiscal Year End December 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9712222132551811925
Cash and cash equivalents9710018529448710425
Short-term investments 2236313015 
Receivables1425201762
Inventory, net of allowances, customer advances and progress billings88110754916127
Inventory88110754916127
Prepaid expense698    
Deposits current assets254527    
Other current assets 12    
Other undisclosed current assets423916495
Total current assets:25933135940055414639
Noncurrent Assets
Operating lease, right-of-use asset18   
Property, plant and equipment184166148129807666
Long-term investments and receivables11422320   
Long-term investments11422320   
Intangible assets, net (including goodwill)392493487520411
Goodwill163163155156   
Intangible assets, net (excluding goodwill)229330332364411
Deposits noncurrent assets 888111
Other undisclosed noncurrent assets32   17  
Total noncurrent assets:6377106666771027868
TOTAL ASSETS:8961,0401,0241,077657224106
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities88965751111013
Accounts payable39592417111013
Accrued liabilities18181819   
Employee-related liabilities25884   
Interest and dividends payable612611   
Debt2 00099
Due to related parties      37
Business combination, contingent consideration, liability0345049   
Other undisclosed current liabilities2069691573
Total current liabilities:92130176170262763
Noncurrent Liabilities
Long-term debt and lease obligation46042843443242998
Long-term debt, excluding current maturities430428425423420  
Finance lease, liability14   
Capital lease obligations99898
Operating lease, liability15   
Liabilities, other than long-term debt0 54934  
Deferred tax liabilities, net54924  
Other liabilities0  1   
Other undisclosed noncurrent liabilities5966     
Total noncurrent liabilities:51949448852443398
Total liabilities:6116246646954593671
Stockholders' equity
Stockholders' equity attributable to parent, including:28541636038219818835
Preferred stock      0
Common stock      0
Additional paid in capital70662352751630226290
Accumulated other comprehensive income10275434
Accumulated deficit(430)(209)(174)(138)(108)(77)(58)
Other undisclosed stockholders' equity attributable to parent000000 
Total stockholders' equity:28541636038219818835
TOTAL LIABILITIES AND EQUITY:8961,0401,0241,077657224106

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues34514621161010
Cost of revenue73(35)(34)(18)(12)(7)(6)
Cost of goods and services sold (3)(4)(3)(0)  
Other undisclosed gross profit(164)  2   
Gross profit:(57)16125334
Operating expenses(178)(46)(37)(28)(22)(12)(10)
Other undisclosed operating income (loss)177(8)(5)(4)(11)(6)
Operating loss:(218)(23)(33)(28)(23)(20)(11)
Nonoperating income (expense)5(1)42(5)2(1)
Foreign currency transaction gain (loss), before tax (3)2(0)(6)2(1)
Other nonoperating income (expense) 12210(0)
Interest and debt expense    (5)  
Other undisclosed loss from continuing operations before equity method investments, income taxes(0)      
Loss from continuing operations before equity method investments, income taxes:(214)(25)(29)(26)(33)(18)(12)
Other undisclosed loss from continuing operations before income taxes(11)(8)(8)(9)(3)(0)(0)
Loss from continuing operations before income taxes:(225)(33)(37)(34)(36)(19)(13)
Income tax expense (benefit)5(3)240(0)(0)
Net loss:(220)(36)(35)(30)(35)(19)(13)
Other undisclosed net income attributable to parent    4  
Net loss attributable to parent:(220)(36)(35)(30)(31)(19)(13)
Other undisclosed net loss available to common stockholders, basic    (0)  
Net loss available to common stockholders, diluted:(220)(36)(35)(30)(31)(19)(13)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(220)(36)(35)(30)(35)(19)(13)
Comprehensive loss:(220)(36)(35)(30)(35)(19)(13)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent7(5)21400
Comprehensive loss, net of tax, attributable to parent:(213)(41)(33)(29)(32)(18)(13)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: